Home > Insider Trading > Filing (0001181431-11-026368)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486420	A Ronald Depinho	C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-04-28	10,000	$14.70	240,012	No	4	S	Direct
Common Stock	Disposition	2011-04-28	10,000	$15.53	230,012	No	4	S	Direct
Common Stock	Disposition	2011-04-28	10,000	$14.69	232,512	No	4	S	Indirect	by spouse
Common Stock	Disposition	2011-04-28	10,000	$15.53	222,512	No	4	S	Indirect	by spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	by spouse
No	4	S	Indirect	by spouse

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2011.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $14.88, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $15.59, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 8, 2011.
These shares are held by the reporting person's spouse. The reporting person disclaims all beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.